MORGAN STANLEY PLC/CALL/CVS HEALTH/93/0.1/20.12.24 Stock

Warrant

DE000MB33TB7

Real-time Bid/Ask 12:21:16 2024-07-11 EDT
0.036 EUR / 0.04 EUR +5.56% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/93/0.1/20.12.24
1 month-7.69%
3 months-59.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 0.037 +2.78%
24-07-10 0.036 0.00%
24-07-09 0.036 +2.86%
24-07-08 0.035 +2.94%
24-07-05 0.034 +13.33%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 09:51 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33TB
ISINDE000MB33TB7
Date issued 2023-02-01
Strike 93 $
Maturity 2024-12-20 (162 Days)
Parity 10 : 1
Emission price 1.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.18
Lowest since issue 0.018
Spread 0.004
Spread %10.00%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.53 USD
Average target price
69.1 USD
Spread / Average Target
+20.10%
Consensus